Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""CALCIUM regulating hormones"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 1598
Tytuł:
Preoperative identification of low-risk medullary thyroid carcinoma: potential application to reduce total thyroidectomy.
Autorzy:
Park H; Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.
Ryu HJ; Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, 115 Irwon-Ro, Gangnam-Gu, Seoul, 06355, Korea.
Heo J; Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju-si, Gangwon-do, Korea.
Chung MK; Department of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Son YI; Department of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Kim JH; Division of Breast and Endocrine Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-Gu, Seoul, 06351, Korea.
Hahn SY; Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Shin JH; Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Oh YL; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Kim SW; Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, 115 Irwon-Ro, Gangnam-Gu, Seoul, 06355, Korea.
Chung JH; Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, 115 Irwon-Ro, Gangnam-Gu, Seoul, 06355, Korea.
Kim JS; Division of Breast and Endocrine Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-Gu, Seoul, 06351, Korea. .
Kim TH; Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, 115 Irwon-Ro, Gangnam-Gu, Seoul, 06355, Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Sep 20; Vol. 13 (1), pp. 15663. Date of Electronic Publication: 2023 Sep 20.
Typ publikacji:
Journal Article
MeSH Terms:
Thyroid Neoplasms*/surgery
Bone Density Conservation Agents*
Humans ; Calcitonin ; Thyroidectomy ; Retrospective Studies ; Calcium-Regulating Hormones and Agents
SCR Disease Name:
Thyroid cancer, medullary
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Development of Molecular Biology of Osteoporosis.
Autorzy:
Gao Y; Tangshan Key Laboratory of Green Speciality Chemicals, Department of Chemistry, Tangshan Normal University, Tangshan 063000, China.
Patil S; Lab for Bone Metabolism, School of Life Sciences, Northwestern Polytechnical University, Xi'an 710072, China.
Jia J; Tangshan Key Laboratory of Green Speciality Chemicals, Department of Chemistry, Tangshan Normal University, Tangshan 063000, China.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Jul 30; Vol. 22 (15). Date of Electronic Publication: 2021 Jul 30.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Bone Density Conservation Agents/*pharmacology
Calcium-Regulating Hormones and Agents/*pharmacology
Osteoporosis/*metabolism
Animals ; Bone Density Conservation Agents/therapeutic use ; Bone Remodeling ; Calcium-Regulating Hormones and Agents/therapeutic use ; Humans ; Osteoclasts/drug effects ; Osteoclasts/metabolism ; Osteoporosis/drug therapy ; Osteoporosis/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cinacalcet may suppress kidney enlargement in hemodialysis patients with autosomal dominant polycystic kidney disease.
Autorzy:
Nakatani S; Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan. .
Nishide K; Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan.
Okuno S; Kidney Center, Shirasagi Hospital, Osaka, Japan.
Ishimura E; Department of Nephrology, Meijibashi Hospital, Osaka, Japan.
Kabata D; Department of Medical Statistics, Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.
Morioka F; Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan.
Machiba Y; Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan.
Uedono H; Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan.
Tsuda A; Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan.
Shoji S; Kidney Center, Shirasagi Hospital, Osaka, Japan.
Inaba M; Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan.
Mori K; Department of Nephrology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Yamakawa T; Kidney Center, Shirasagi Hospital, Osaka, Japan.
Emoto M; Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan.; Department of Nephrology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 May 11; Vol. 11 (1), pp. 10014. Date of Electronic Publication: 2021 May 11.
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Calcium-Regulating Hormones and Agents/*therapeutic use
Cinacalcet/*therapeutic use
Kidney/*drug effects
Kidney Failure, Chronic/*drug therapy
Polycystic Kidney, Autosomal Dominant/*drug therapy
Aged ; Calcium/blood ; Calcium-Regulating Hormones and Agents/pharmacology ; Cinacalcet/pharmacology ; Female ; Humans ; Hypertrophy/etiology ; Hypertrophy/prevention & control ; Kidney/pathology ; Kidney Failure, Chronic/blood ; Kidney Failure, Chronic/complications ; Kidney Failure, Chronic/pathology ; Male ; Middle Aged ; Organ Size/drug effects ; Parathyroid Hormone/blood ; Phosphates/blood ; Polycystic Kidney, Autosomal Dominant/blood ; Polycystic Kidney, Autosomal Dominant/complications ; Polycystic Kidney, Autosomal Dominant/pathology ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Case report of a cystic parathyroidal adenoma with rapid growth induced by cinacalcet.
Autorzy:
Werner C; Clinic of Internal Medicine III, Jena University Hospital, Am Klinikum 1, 07747, Jena, Thuringia, Germany. .
Lupp A; Institute of Pharmacology and Toxicology, Jena University Hospital, Jena, Germany.
Mtuka-Pardon G; Clinic of General, Visceral and Vascular Surgery, Jena University Hospital, Jena, Germany.
Kloos C; Clinic of Internal Medicine III, Jena University Hospital, Am Klinikum 1, 07747, Jena, Thuringia, Germany.
Wolf G; Clinic of Internal Medicine III, Jena University Hospital, Am Klinikum 1, 07747, Jena, Thuringia, Germany.
Aschenbach R; Department of Radiology, Jena University Hospital, Jena, Germany.
Biermann A; Institute of Pathology, Jena University Hospital, Jena, Germany.
Freesmeyer M; Clinic of Nuclear Medicine, Jena University Hospital, Jena, Germany.
Seifert P; Clinic of Nuclear Medicine, Jena University Hospital, Jena, Germany.
Pokaż więcej
Źródło:
BMC endocrine disorders [BMC Endocr Disord] 2020 Apr 20; Vol. 20 (1), pp. 53. Date of Electronic Publication: 2020 Apr 20.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Adenoma/*diagnosis
Calcium-Regulating Hormones and Agents/*adverse effects
Cinacalcet/*adverse effects
Hypercalcemia/*drug therapy
Hyperparathyroidism, Primary/*drug therapy
Parathyroid Neoplasms/*diagnosis
Adenoma/complications ; Adenoma/surgery ; Biopsy ; Calcium-Regulating Hormones and Agents/therapeutic use ; Cinacalcet/therapeutic use ; Cysts/diagnosis ; Diagnostic Errors ; Disease Progression ; Female ; Humans ; Hypercalcemia/diagnosis ; Hypercalcemia/etiology ; Hyperparathyroidism, Primary/diagnosis ; Hyperparathyroidism, Primary/etiology ; Magnetic Resonance Imaging ; Middle Aged ; Parathyroid Neoplasms/complications ; Parathyroid Neoplasms/surgery ; Radionuclide Imaging ; Thyroid Diseases/diagnosis ; Tumor Burden ; Ultrasonography
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Enhancement of the effects of intermittent parathyroid hormone (1-34) by bone morphogenetic protein in a rat femoral open fracture model.
Autorzy:
Kanezaki S; Department of Orthopaedic Surgery, Faculty of Medicine, Oita University, Yufu-shi, Oita, 879-5593, Japan.; Advanced Trauma, Emergency, and Critical Care Center, Oita University Hospital, Oita, Japan.
Miyazaki M; Department of Orthopaedic Surgery, Faculty of Medicine, Oita University, Yufu-shi, Oita, 879-5593, Japan. .
Ishihara T; Department of Orthopaedic Surgery, Faculty of Medicine, Oita University, Yufu-shi, Oita, 879-5593, Japan.
Notani N; Department of Orthopaedic Surgery, Faculty of Medicine, Oita University, Yufu-shi, Oita, 879-5593, Japan.; Advanced Trauma, Emergency, and Critical Care Center, Oita University Hospital, Oita, Japan.
Abe T; Department of Orthopaedic Surgery, Faculty of Medicine, Oita University, Yufu-shi, Oita, 879-5593, Japan.
Tsubouchi Y; Department of Rehabilitation, Oita University Hospital, Oita, Japan.
Kataoka M; Physical Therapy Course of Study, Faculty of Welfare and Health Sciences, Oita University, Oita, Japan.
Tsumura H; Department of Orthopaedic Surgery, Faculty of Medicine, Oita University, Yufu-shi, Oita, 879-5593, Japan.
Pokaż więcej
Źródło:
Journal of orthopaedic surgery and research [J Orthop Surg Res] 2019 Nov 29; Vol. 14 (1), pp. 403. Date of Electronic Publication: 2019 Nov 29.
Typ publikacji:
Journal Article
MeSH Terms:
Bone Morphogenetic Proteins/*therapeutic use
Calcium-Regulating Hormones and Agents/*therapeutic use
Femoral Fractures/*drug therapy
Fractures, Open/*drug therapy
Parathyroid Hormone/*therapeutic use
Animals ; Bone Morphogenetic Proteins/pharmacology ; Calcium-Regulating Hormones and Agents/pharmacology ; Drug Evaluation, Preclinical ; Drug Therapy, Combination ; Femoral Fractures/diagnostic imaging ; Fracture Healing/drug effects ; Fractures, Open/diagnostic imaging ; Male ; Rats, Sprague-Dawley ; X-Ray Microtomography
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Osteoclast-Released Wnt-10b Underlies Cinacalcet Related Bone Improvement in Chronic Kidney Disease.
Autorzy:
Zheng CM; Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan. .; Division of Nephrology, Department of Internal Medicine, School of Medicine, Taipei Medical University, New Taipei City 235, Taiwan. .; Division of Nephrology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City 235, Taiwan. .
Hsu YH; Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan. .; Division of Nephrology, Department of Internal Medicine, School of Medicine, Taipei Medical University, New Taipei City 235, Taiwan. .; Division of Nephrology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City 235, Taiwan. .
Wu CC; Division of Nephrology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 10581, Taiwan. .
Lu CL; Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan. .; Division of Nephrology, Department of Medicine, Fu Jen Catholic University Hospital, School of Medicine, Fu Jen Catholic University, New Taipei City 243, Taiwan. .
Liu WC; Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan. .; Division of Nephrology, Department of Internal Medicine, Tungs' Taichung Metroharbor Hospital, Taichung City 43304, Taiwan. .
Zheng JQ; Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan. .; Department of Critical Care Medicine, Shuang Ho Hospital, Taipei Medical University, Taipei 235, Taiwan. .
Lin YF; Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan. .; Division of Nephrology, Department of Internal Medicine, School of Medicine, Taipei Medical University, New Taipei City 235, Taiwan. .; Division of Nephrology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City 235, Taiwan. .
Chiu HW; Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan. .; Division of Nephrology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City 235, Taiwan. .
Chang TJ; Graduate Institute of Life Sciences, National Defense Medical Center, Taipei 114, Taiwan. .; Performance Appraisal Section, Secretary Office, Shuang Ho Hospital, Taipei Medical University, New Taipei City 235, Taiwan. .
Shyu JF; Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan. .; Department of Biology and Anatomy, National Defense Medical Center, Taipei 110, Taiwan. .
Lu KC; Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan. .; Division of Nephrology, Department of Medicine, Fu Jen Catholic University Hospital, School of Medicine, Fu Jen Catholic University, New Taipei City 243, Taiwan. .
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2019 Jun 08; Vol. 20 (11). Date of Electronic Publication: 2019 Jun 08.
Typ publikacji:
Journal Article
MeSH Terms:
Bone Resorption/*metabolism
Calcium-Regulating Hormones and Agents/*pharmacology
Cinacalcet/*pharmacology
Osteoclasts/*drug effects
Renal Insufficiency, Chronic/*complications
Wnt Proteins/*metabolism
Animals ; Bone Density ; Bone Resorption/drug therapy ; Bone Resorption/etiology ; Calcium-Regulating Hormones and Agents/therapeutic use ; Cells, Cultured ; Cinacalcet/therapeutic use ; Male ; Mice ; Mice, Inbred C57BL ; Osteoclasts/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Medical Treatment for Osteoporosis: From Molecular to Clinical Opinions.
Autorzy:
Chen LR; Department of Physical Medicine and Rehabilitation, Mackay Memorial Hospital, Taipei 10449, Taiwan. .; Department of Mechanical Engineering, National Chiao-Tung University, Hsinchu 30010, Taiwan. .
Ko NY; Department of Physical Medicine and Rehabilitation, Mackay Memorial Hospital, Taipei 10449, Taiwan. .
Chen KH; Department of Obstetrics and Gynecology, Taipei Tzu-Chi Hospital, The Buddhist Tzu-Chi Medical Foundation, Taipei 23142, Taiwan. .; School of Medicine, Tzu-Chi University, Hualien 97004, Taiwan. .
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2019 May 06; Vol. 20 (9). Date of Electronic Publication: 2019 May 06.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Bone Density Conservation Agents/*therapeutic use
Calcium-Regulating Hormones and Agents/*therapeutic use
Osteoporosis/*drug therapy
Animals ; Bone Density/drug effects ; Bone Density/genetics ; Bone Density Conservation Agents/pharmacology ; Calcium-Regulating Hormones and Agents/pharmacology ; Humans ; Osteoporosis/genetics ; Osteoporosis/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Improved Control of Secondary Hyperparathyroidism in Hemodialysis Patients Switching from Oral Cinacalcet to Intravenous Etelcalcetide, Especially in Nonadherent Patients.
Autorzy:
Xipell M; Department of Nephrology and Renal Transplantation, Hospital Clínic de Barcelona, Barcelona, Spain.
Montagud-Marrahi E; Department of Nephrology and Renal Transplantation, Hospital Clínic de Barcelona, Barcelona, Spain.
Rubio MV; Department of Nephrology and Renal Transplantation, Hospital Clínic de Barcelona, Barcelona, Spain.
Ojeda R; Department of Nephrology and Renal Transplantation, Hospital Clínic de Barcelona, Barcelona, Spain.
Arias-Guillén M; Department of Nephrology and Renal Transplantation, Hospital Clínic de Barcelona, Barcelona, Spain.
Fontseré N; Department of Nephrology and Renal Transplantation, Hospital Clínic de Barcelona, Barcelona, Spain.
Rodas L; Department of Nephrology and Renal Transplantation, Hospital Clínic de Barcelona, Barcelona, Spain.
Vera M; Department of Nephrology and Renal Transplantation, Hospital Clínic de Barcelona, Barcelona, Spain.
Broseta JJ; Department of Nephrology and Renal Transplantation, Hospital Clínic de Barcelona, Barcelona, Spain.
Torregrosa V; Department of Nephrology and Renal Transplantation, Hospital Clínic de Barcelona, Barcelona, Spain.
Filella X; Department of Biochemistry and Molecular Genetics, Hospital Clínic de Barcelona, Barcelona, Spain.
Maduell F; Department of Nephrology and Renal Transplantation, Hospital Clínic de Barcelona, Barcelona, Spain, .
Pokaż więcej
Źródło:
Blood purification [Blood Purif] 2019; Vol. 48 (2), pp. 106-114. Date of Electronic Publication: 2019 Jan 30.
Typ publikacji:
Journal Article
MeSH Terms:
Calcium-Regulating Hormones and Agents/*therapeutic use
Cinacalcet/*therapeutic use
Hyperparathyroidism, Secondary/*drug therapy
Peptides/*therapeutic use
Administration, Intravenous ; Administration, Oral ; Adult ; Aged ; Aged, 80 and over ; Calcium/blood ; Calcium-Regulating Hormones and Agents/administration & dosage ; Cinacalcet/administration & dosage ; Female ; Humans ; Hyperparathyroidism, Secondary/blood ; Hyperparathyroidism, Secondary/therapy ; Male ; Middle Aged ; Patient Compliance ; Peptides/administration & dosage ; Prospective Studies ; Renal Dialysis ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Effect Of Vitamin D Levels On Eradication Of Helicobacter Pylori Infection.
Autorzy:
Kılıç, Güner
Kılıç, Gülce Ecem
Özkahraman, Adnan
Konür, Şevki
Kayar, Yusuf
Pokaż więcej
Temat:
VITAMIN D
HELICOBACTER pylori infections
HELICOBACTER diseases
CALCIUM regulating hormones
FAT-soluble vitamins
Alternatywny tytuł:
Helicobacter Pilori Eradikasyonunda D Vitamini Düzeylerinin Etkisi. (Turkish)
Źródło:
Hitit Medical Journal; Feb2024, Vol. 6 Issue 1, p28-32, 5p
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Characterization of Medication Trends for Chronic Kidney Disease: Mineral and Bone Disorder Treatment Using Electronic Health Record-Based Common Data Model.
Autorzy:
Han S; Department of Nephrology, Ajou University School of Medicine, 164, Worldcup-ro, Yeongtong-gu, Suwon, Gyeonggi-do 16499, Republic of Korea.
Son M; Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, 123, Cheomdangwagi-ro, Buk-gu, Gwangju 61005, Republic of Korea.
Choi B; Department of Biomedical Informatics, Ajou University School of Medicine, 164, Worldcup-ro, Yeongtong-gu, Suwon, Gyeonggi-do 16499, Republic of Korea.
Park C; Department of Biomedical Informatics, Ajou University School of Medicine, 164, Worldcup-ro, Yeongtong-gu, Suwon, Gyeonggi-do 16499, Republic of Korea.
Shin DH; Department of Internal Medicine, College of Medicine, Hallym University, Kandong Sacred Heart Hospital, 150, Seongan-ro, Gangdong-gu, Seoul 05355, Republic of Korea.
Jung JH; Division of Nephrology, Department of Internal Medicine, Wonkwang University School of Medicine and Hospital, 895, Muwang-ro, Iksan, Jeollabuk-do 54538, Republic of Korea.
Lee MJ; Department of Nephrology, Ajou University School of Medicine, 164, Worldcup-ro, Yeongtong-gu, Suwon, Gyeonggi-do 16499, Republic of Korea.
Shin GT; Department of Nephrology, Ajou University School of Medicine, 164, Worldcup-ro, Yeongtong-gu, Suwon, Gyeonggi-do 16499, Republic of Korea.
Kim H; Department of Nephrology, Ajou University School of Medicine, 164, Worldcup-ro, Yeongtong-gu, Suwon, Gyeonggi-do 16499, Republic of Korea.
Park RW; Department of Biomedical Informatics, Ajou University School of Medicine, 164, Worldcup-ro, Yeongtong-gu, Suwon, Gyeonggi-do 16499, Republic of Korea.; Department of Biomedical Sciences, Ajou University Graduate School of Medicine, 164, Worldcup-ro, Yeongtong-gu, Suwon, Gyeonggi-do 16499, Republic of Korea.
Park I; Department of Nephrology, Ajou University School of Medicine, 164, Worldcup-ro, Yeongtong-gu, Suwon, Gyeonggi-do 16499, Republic of Korea.
Pokaż więcej
Źródło:
BioMed research international [Biomed Res Int] 2021 Nov 22; Vol. 2021, pp. 5504873. Date of Electronic Publication: 2021 Nov 22 (Print Publication: 2021).
Typ publikacji:
Journal Article; Multicenter Study; Observational Study
MeSH Terms:
Chronic Kidney Disease-Mineral and Bone Disorder/*drug therapy
Adult ; Aged ; Aged, 80 and over ; Calcium-Regulating Hormones and Agents/therapeutic use ; Chronic Kidney Disease-Mineral and Bone Disorder/etiology ; Cinacalcet/therapeutic use ; Electronic Health Records ; Female ; Hospitals, University ; Humans ; Male ; Middle Aged ; Practice Guidelines as Topic ; Receptors, Calcitriol/agonists ; Renal Insufficiency, Chronic/complications ; Republic of Korea ; Retrospective Studies ; Tertiary Care Centers
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
1α,25-dihydroxyvitamin D 3 protects retinal ganglion cells in glaucomatous mice.
Autorzy:
Lazzara F; Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, School of Medicine, University of Catania, Catania, Italy.; Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, FL, USA.
Amato R; Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, FL, USA.; Department of Biology, University of Pisa, Pisa, Italy.
Platania CBM; Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, School of Medicine, University of Catania, Catania, Italy.
Conti F; Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, School of Medicine, University of Catania, Catania, Italy.
Chou TH; Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, FL, USA.
Porciatti V; Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, FL, USA.
Drago F; Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, School of Medicine, University of Catania, Catania, Italy.; Center for Research in Ocular Pharmacology - CERFO, University of Catania, Catania, Italy.
Bucolo C; Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, School of Medicine, University of Catania, Catania, Italy. .; Center for Research in Ocular Pharmacology - CERFO, University of Catania, Catania, Italy. .
Pokaż więcej
Źródło:
Journal of neuroinflammation [J Neuroinflammation] 2021 Sep 16; Vol. 18 (1), pp. 206. Date of Electronic Publication: 2021 Sep 16.
Typ publikacji:
Journal Article
MeSH Terms:
Calcitriol/*administration & dosage
Glaucoma/*metabolism
Glaucoma/*prevention & control
Neuroprotective Agents/*administration & dosage
Retinal Ganglion Cells/*drug effects
Retinal Ganglion Cells/*metabolism
Animals ; Calcium-Regulating Hormones and Agents/administration & dosage ; Female ; Gene Regulatory Networks/drug effects ; Gene Regulatory Networks/physiology ; Glaucoma/genetics ; Mice ; Mice, Inbred DBA ; Mice, Transgenic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The impact of CASR A990G polymorphism in response to cinacalcet treatment in hemodialysis patients with secondary hyperparathyroidism.
Autorzy:
Ngamkam J; Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand.
Vadcharavivad S; Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand. .
Areepium N; Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand.
Auamnoy T; Faculty of Pharmaceutical Sciences, Burapha University, Chon Buri, 20131, Thailand.
Takkavatakarn K; Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand.
Katavetin P; Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand.
Tiranathanagul K; Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand.
Praditpornsilpa K; Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand.; Excellent Center of Geriatrics, King Chulalongkorn Memorial Hospital, Bangkok, 10330, Thailand.
Eiam-Ong S; Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand.
Susantitaphong P; Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Sep 09; Vol. 11 (1), pp. 18006. Date of Electronic Publication: 2021 Sep 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Polymorphism, Single Nucleotide*
Calcium-Regulating Hormones and Agents/*therapeutic use
Cinacalcet/*therapeutic use
Hyperparathyroidism, Secondary/*therapy
Receptors, Calcium-Sensing/*genetics
Renal Insufficiency, Chronic/*therapy
Age Factors ; Aged ; Alleles ; Calcitriol/blood ; Calcium/blood ; Ergocalciferols/blood ; Female ; Gene Expression ; Genotype ; Heterozygote ; Homozygote ; Humans ; Hyperparathyroidism, Secondary/blood ; Hyperparathyroidism, Secondary/genetics ; Hyperparathyroidism, Secondary/pathology ; Logistic Models ; Male ; Middle Aged ; Parathyroid Hormone/blood ; Parathyroid Hormone/genetics ; Phosphates/blood ; Receptors, Calcium-Sensing/blood ; Renal Dialysis/methods ; Renal Insufficiency, Chronic/blood ; Renal Insufficiency, Chronic/genetics ; Renal Insufficiency, Chronic/pathology ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Associations between Osteocalcin, Calciotropic Hormones, and Energy Metabolism in a Cohort of Chinese Postmenopausal Women: Peking Vertebral Fracture Study.
Autorzy:
Jiajue, Ruizhi (AUTHOR)
Liu, Shuying (AUTHOR)
Pei, Yu (AUTHOR)
Qi, Xuan (AUTHOR)
Jiang, Yan (AUTHOR)
Wang, Qiuping (AUTHOR)
Wang, Wenbo (AUTHOR)
Wang, Xiran (AUTHOR)
Huang, Wei (AUTHOR)
Zheng, Xin (AUTHOR)
Ning, Zhiwei (AUTHOR)
Wang, Ou (AUTHOR)
Li, Mei (AUTHOR)
Xing, Xiaoping (AUTHOR)
Yu, Wei (AUTHOR)
Xu, Ling (AUTHOR)
Xia, Weibo (AUTHOR)
Pokaż więcej
Źródło:
International Journal of Endocrinology. 3/25/2021, p1-10. 10p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effects of intravenous magnesium sulfate on serum calcium-regulating hormones and plasma and urinary electrolytes in healthy horses.
Autorzy:
Schumacher SA; College of Veterinary Medicine, The Ohio State University, Columbus, OH, United States of America.; United States Equestrian Federation, Columbus, Ohio, United States of America.
Kamr AM; College of Veterinary Medicine, The Ohio State University, Columbus, OH, United States of America.; Faculty of Veterinary Medicine, University of Sadat City, Sadat City, Egypt.
Lakritz J; College of Veterinary Medicine, The Ohio State University, Columbus, OH, United States of America.
Burns TA; College of Veterinary Medicine, The Ohio State University, Columbus, OH, United States of America.
Bertone AL; College of Veterinary Medicine, The Ohio State University, Columbus, OH, United States of America.
Toribio RE; College of Veterinary Medicine, The Ohio State University, Columbus, OH, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Jun 28; Vol. 16 (6), pp. e0247542. Date of Electronic Publication: 2021 Jun 28 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Calcium/*metabolism
Electrolytes/*metabolism
Magnesium Sulfate/*pharmacology
Administration, Intravenous/methods ; Animals ; Calcitonin/blood ; Calcitonin/urine ; Calcium/blood ; Calcium-Regulating Hormones and Agents/metabolism ; Chlorides/blood ; Chlorides/urine ; Electrolytes/blood ; Electrolytes/urine ; Female ; Horse Diseases/blood ; Horses/metabolism ; Magnesium/blood ; Magnesium/metabolism ; Magnesium Sulfate/administration & dosage ; Parathyroid Hormone/blood ; Parathyroid Hormone/urine ; Potassium/blood ; Potassium/urine ; Sodium/blood ; Sodium/urine
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Calcium-based phosphate binder use is associated with lower risk of osteoporosis in hemodialysis patients.
Autorzy:
Hashimoto H; Department of Nephrology, Shuuwa General Hospital, 1200 Yaharashinden, Kasukabe, Saitama, 344-0035, Japan.
Shikuma S; Department of Nephrology, Shuuwa General Hospital, 1200 Yaharashinden, Kasukabe, Saitama, 344-0035, Japan.
Mandai S; Department of Nephrology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo, 113-8519, Japan. .
Adachi S; Department of Cardiology, Shuuwa General Hospital, 1200 Yaharashinden, Kasukabe, Saitama, 344-0035, Japan.
Uchida S; Department of Nephrology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo, 113-8519, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Jan 18; Vol. 11 (1), pp. 1648. Date of Electronic Publication: 2021 Jan 18.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Bone Density/*drug effects
Calcium/*therapeutic use
Osteoporosis/*prevention & control
Phosphates/*therapeutic use
Renal Dialysis/*methods
Vitamin D/*therapeutic use
Aged ; Calcium-Regulating Hormones and Agents/therapeutic use ; Cross-Sectional Studies ; Female ; Humans ; Male ; Middle Aged ; Osteoporosis/etiology ; Osteoporosis/pathology ; Renal Dialysis/adverse effects ; Renal Dialysis/instrumentation ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Intramedullary injury combined with osteoporosis therapeutics regulates targeted local osteogenesis.
Autorzy:
Miyazaki-Asato Y; Department of Oral Rehabilitation, Oral Implantology, Fukuoka Dental College, Fukuoka, Japan.
Koi K; Department of Restorative Dentistry, Oregon Health & Science University School of Dentistry, Portland, OR, USA.
Fujimoto H; Department of Oral Rehabilitation, Fukuoka Dental College, Fukuoka, Japan.
Kakura K; Department of Oral Rehabilitation, Oral Implantology, Fukuoka Dental College, Fukuoka, Japan.
Kido H; Department of Oral Rehabilitation, Oral Implantology, Fukuoka Dental College, Fukuoka, Japan.
Yanagi T; Department of Oral Rehabilitation, Oral Implantology, Fukuoka Dental College, Fukuoka, Japan.
Yamashita J; Department of Oral Rehabilitation, Fukuoka Dental College, Fukuoka, Japan. .; Center for Regenerative Medicine, Fukuoka Dental College, Sawara-ku Tamura 2-15-1, Fukuoka, 814-0193, Japan. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Jan 12; Vol. 11 (1), pp. 205. Date of Electronic Publication: 2021 Jan 12.
Typ publikacji:
Journal Article
MeSH Terms:
Osteogenesis*
Alendronate/*therapeutic use
Bone Density Conservation Agents/*therapeutic use
Calcium-Regulating Hormones and Agents/*therapeutic use
Osteoporosis/*complications
Parathyroid Hormone/*therapeutic use
Tibia/*injuries
Animals ; Bone Marrow/drug effects ; Bone Marrow/injuries ; Bone Marrow/metabolism ; Bone Marrow/pathology ; Bone Regeneration/drug effects ; Bone Regeneration/physiology ; Cancellous Bone/drug effects ; Cancellous Bone/injuries ; Cancellous Bone/metabolism ; Cancellous Bone/pathology ; Diaphyses/drug effects ; Diaphyses/injuries ; Diaphyses/metabolism ; Diaphyses/pathology ; Implants, Experimental ; Male ; Osteocalcin/blood ; Rats, Sprague-Dawley ; Serum/chemistry ; Tibia/drug effects ; Tibia/metabolism ; Tibia/pathology ; Tissue Engineering/methods ; Tomography, X-Ray Computed ; Rats
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Current Evidence and Future Perspectives on Pharmacological Treatment of Calcific Aortic Valve Stenosis.
Autorzy:
Donato M; Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35122 Padova, Italy.
Ferri N; Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35122 Padova, Italy.
Lupo MG; Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35122 Padova, Italy.
Faggin E; Department of Medicine-DIMED, University of Padova, 35122 Padova, Italy.
Rattazzi M; Department of Medicine-DIMED, University of Padova, 35122 Padova, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2020 Nov 04; Vol. 21 (21). Date of Electronic Publication: 2020 Nov 04.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Aortic Valve/*pathology
Aortic Valve Stenosis/*drug therapy
Calcinosis/*drug therapy
Drug Discovery/*trends
Aortic Valve/surgery ; Aortic Valve Stenosis/complications ; Aortic Valve Stenosis/etiology ; Aortic Valve Stenosis/surgery ; Calcinosis/complications ; Calcinosis/surgery ; Calcium-Regulating Hormones and Agents/therapeutic use ; Disease Progression ; Drug Discovery/methods ; Heart Valve Prosthesis ; Humans ; Hypolipidemic Agents/therapeutic use ; Lipid Metabolism/drug effects ; Vasoconstrictor Agents/therapeutic use
SCR Disease Name:
Aortic Valve, Calcification of
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 1598

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies